Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission.
Sign Up to like & getrecommendations! Published in 2019 at "American heart journal"
DOI: 10.1016/j.ahj.2019.02.016
Abstract: Prior studies reported that Myeloperoxidase and Galectin-3, which are biomarkers of coronary plaque vulnerability, are elevated in acute coronary syndrome (ACS) patients. We studied the temporal evolution of these biomarkers early after ACS admission and… read more here.
Keywords: acute coronary; myeloperoxidase galectin; admission; coronary syndrome ... See more keywords